PLoS ONE (Jan 2021)
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
- Paul Jank,
- Claire Gehlhaar,
- Bianca Lederer,
- Caterina Fontanella,
- Andreas Schneeweiss,
- Thomas Karn,
- Frederik Marmé,
- Hans-Peter Sinn,
- Marion van Mackelenbergh,
- Bruno Sinn,
- Dirk-Michael Zahm,
- Barbara Ingold-Heppner,
- Christian Schem,
- Elmar Stickeler,
- Peter A Fasching,
- Valentina Nekljudova,
- Eliane Tabea Taube,
- Frank Heppner,
- Volkmar Müller,
- Carsten Denkert,
- Sibylle Loibl
Affiliations
- Paul Jank
- Claire Gehlhaar
- Bianca Lederer
- Caterina Fontanella
- Andreas Schneeweiss
- Thomas Karn
- Frederik Marmé
- Hans-Peter Sinn
- Marion van Mackelenbergh
- Bruno Sinn
- Dirk-Michael Zahm
- Barbara Ingold-Heppner
- Christian Schem
- Elmar Stickeler
- Peter A Fasching
- Valentina Nekljudova
- Eliane Tabea Taube
- Frank Heppner
- Volkmar Müller
- Carsten Denkert
- Sibylle Loibl
- DOI
- https://doi.org/10.1371/journal.pone.0257142
- Journal volume & issue
-
Vol. 16,
no. 9
p. e0257142
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0238021.].